1207108-98-2

Upstream product

• 57-88-5 cholesterol 
• 177582-21-7 fmoc-S-4-methoxytrityl-L-cysteine 

Downstream Products

• 1373121-76-6 cholest-5-en-3-yl (13R)-13-amino-2-{4-[(hydroxyamino)carbonyl]benzyl}-1-(2-naphthyl)-6-oxo-5,7-dioxa-10,11-dithia-2-azatetradecan-14-oate 
• 1207108-99-3 cholest-5-en-3-yl (2R)-2-amino-3-{[(4-methoxyphenyl)(diphenyl)methyl]sulfanyl}propanoate 
• 1207109-01-0 cholest-5-en-3-yl (13R)-13-amino-1-(2-naphthyl)-6-oxo-2-(4-{[(tetrahydro-2H-pyran-2-yloxy)amino]carbonyl}benzyl)-5,7-dioxa-10,11-dithia-2-azatetradecan-14-oate 

Relevant academic research and scientific papers

Antitumor effect of liposomal histone deacetylase inhibitor-lipid conjugates in vitro

Histone deacetylase inhibitor (HDACI), suberoylanilide hydroxamic acid (SAHA), approved by the Food and Drug Administration (FDA) for the treatment of cutaneous T cell lymphoma, is a promising new treatment strategy for various cancers. In this study, we